These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11600538)

  • 1. GH is needed for the maturation of muscle mass and strength in adolescents.
    Hulthén L; Bengtsson BA; Sunnerhagen KS; Hallberg L; Grimby G; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4765-70. PubMed ID: 11600538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.
    Koranyi J; Svensson J; Götherström G; Sunnerhagen KS; Bengtsson B; Johannsson G
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4693-9. PubMed ID: 11600527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of growth hormone replacement therapy in adults: age- and gender-related changes in isometric and isokinetic muscle strength.
    Svensson J; Sunnerhagen KS; Johannsson G
    J Clin Endocrinol Metab; 2003 May; 88(5):2061-9. PubMed ID: 12727955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.
    Götherström G; Elbornsson M; Stibrant-Sunnerhagen K; Bengtsson BA; Johannsson G; Svensson J
    J Clin Endocrinol Metab; 2009 Mar; 94(3):809-16. PubMed ID: 19088164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
    Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.
    Johannsson G; Albertsson-Wikland K; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4516-24. PubMed ID: 10599711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle characteristics and motor performance after 2-year growth hormone treatment in adults with prader-willi syndrome.
    Lafortuna CL; Minocci A; Capodaglio P; Gondoni LA; Sartorio A; Vismara L; Rizzo G; Grugni G
    J Clin Endocrinol Metab; 2014 May; 99(5):1816-24. PubMed ID: 24471571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.
    Johannsson G; Grimby G; Sunnerhagen KS; Bengtsson BA
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2877-84. PubMed ID: 9284713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
    Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement.
    Götherström G; Elbornsson M; Stibrant-Sunnerhagen K; Bengtsson BA; Johannsson G; Svensson J
    Eur J Endocrinol; 2010 Aug; 163(2):207-15. PubMed ID: 20463152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in muscle volume, strength, and bioenergetics during recombinant human growth hormone (GH) therapy in adults with GH deficiency.
    Janssen YJ; Doornbos J; Roelfsema F
    J Clin Endocrinol Metab; 1999 Jan; 84(1):279-84. PubMed ID: 9920096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal determinants of regional body composition in adolescent girls with anorexia nervosa and controls.
    Misra M; Miller KK; Almazan C; Worley M; Herzog DB; Klibanski A
    J Clin Endocrinol Metab; 2005 May; 90(5):2580-7. PubMed ID: 15713709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial.
    Mauras N; Pescovitz OH; Allada V; Messig M; Wajnrajch MP; Lippe B;
    J Clin Endocrinol Metab; 2005 Jul; 90(7):3946-55. PubMed ID: 15855257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
    Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study.
    Underwood LE; Attie KM; Baptista J;
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5273-80. PubMed ID: 14602761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects.
    Kuromaru R; Kohno H; Ueyama N; Hassan HM; Honda S; Hara T
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3890-6. PubMed ID: 9814464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle strength and body composition during the transition phase in patients treated with recombinant GH to final height.
    Modesto Mde J; Amer NM; Erichsen O; Hernandez S; dos Santos CD; de Carvalho JÂ; Pereira RM; França SN; De Lacerda L
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):813-20. PubMed ID: 24756044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone increases muscle mass and strength but does not rejuvenate myofibrillar protein synthesis in healthy subjects over 60 years old.
    Welle S; Thornton C; Statt M; McHenry B
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3239-43. PubMed ID: 8784075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.